Pediatric glioblastoma - unlike normal cells - are sensitive to the combination of vorinostat and olaparib and to its downstream effector - phosphorylated eIF2αKarin Eytan(Sheba Medical Center), Michal Yalon(Sheba Medical Center)bioRxiv (Cold Spring Harbor Laboratory)November 25, 202010.1101/2020.11.25.397497Cited by 0SaveCiteExport RISWatch citationsRelated PapersOvercoming Resistance of Cancer Cells to PARP-1 Inhibitors with Three Different Drug Combinations|PLoS ONE|2016|24MutT homolog 1 counteracts the effect of anti-neoplastic treatments in adult and pediatric glioblastoma cells|Oncotarget|2018|15